Cargando…
Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
INTRODUCTION: The purpose of this study was to investigate the efficacy and safety of consecutive use of 1% and 0.01% atropine compared with 0.01% atropine alone over 1 year. METHODS: A total of 207 participants aged 6–12 years with myopia of − 0.50 to − 6.00 D in both eyes were enrolled in this ran...
Autores principales: | Ye, Luyao, Xu, Hannan, Shi, Ya, Yin, Yao, Yu, Tao, Peng, Yajun, Li, Shanshan, He, Jiangnan, Zhu, Jianfeng, Xu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521881/ https://www.ncbi.nlm.nih.gov/pubmed/36175821 http://dx.doi.org/10.1007/s40123-022-00572-1 |
Ejemplares similares
-
Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022) -
Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023) -
Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020) -
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020) -
A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)